Welcome to LookChem.com Sign In|Join Free
  • or
1-hydroxynaphthalene-2-carbonyl chloride is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

38077-69-9

Post Buying Request

38077-69-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

38077-69-9 Usage

Carbonyl chloride derivative

1-hydroxynaphthalene-2-carbonyl chloride is derived from 1-hydroxy-2-naphthoic acid by replacing the carboxyl group (-COOH) with a chlorine atom, forming a carbonyl chloride group (-CCl).

Reactivity

1-hydroxynaphthalene-2-carbonyl chloride is a reactive chemical reagent, which allows it to participate in various chemical reactions and form a wide range of organic molecules.

Versatility

1-hydroxynaphthalene-2-carbonyl chloride can be used in the preparation of diverse chemical compounds and pharmaceuticals, making it a valuable building block in organic synthesis.

Pharmaceutical industry application

1-hydroxynaphthalene-2-carbonyl chloride is commonly used as an intermediate in the synthesis of various pharmaceutical compounds.

Potential use in bioactive molecules

1-hydroxynaphthalene-2-carbonyl chloride is known for its potential use in the synthesis of bioactive molecules, which can have various biological effects and applications in medicine.

Key reagent in organic synthesis

Due to its reactivity and versatility, 1-hydroxynaphthalene-2-carbonyl chloride can be employed as a key reagent in the synthesis of a variety of organic compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 38077-69-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,0,7 and 7 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 38077-69:
(7*3)+(6*8)+(5*0)+(4*7)+(3*7)+(2*6)+(1*9)=139
139 % 10 = 9
So 38077-69-9 is a valid CAS Registry Number.

38077-69-9Relevant academic research and scientific papers

SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway

Chae, Hee-Don,Cox, Nick,Capolicchio, Samanta,Lee, Jae Wook,Horikoshi,Kam, Sharon,Ng, Andrew A.,Edwards, Jeffrey,Butler, Tae-León,Chan, Justin,Lee, Yvonne,Potter, Garrett,Capece, Mark C.,Liu, Corey W.,Wakatsuki, Soichi,Smith, Mark,Sakamoto, Kathleen M.

supporting information, p. 2307 - 2315 (2019/06/27)

Disruption of cyclic adenosine monophosphate response element binding protein (CREB) provides a potential new strategy to address acute leukemia, a disease associated with poor prognosis, and for which conventional treatment options often carry a significant risk of morbidity and mortality. We describe the structure-activity relationships (SAR) for a series of XX-650-23 derived from naphthol AS-E phosphate that disrupts binding and activation of CREB by the CREB-binding protein (CBP). Through the development of this series, we identified several salicylamides that are potent inhibitors of acute leukemia cell viability through inhibition of CREB-CBP interaction. Among them, a biphenyl salicylamide, compound 71, was identified as a potent inhibitor of CREB-CBP interaction with improved physicochemical properties relative to previously described derivatives of naphthol AS-E phosphate.

Searching new structural scaffolds for BRAF inhibitors. An integrative study using theoretical and experimental techniques

Campos, Ludmila E.,Garibotto, Francisco M.,Angelina, Emilio,Kos, Jiri,Toma?i?, Tihomir,Zidar, Nace,Kikelj, Danijel,Gonec,Marvanova, Pavlina,Mokry, Petr,Jampilek,Alvarez, Sergio E.,Enriz, Ricardo D.

, (2019/08/12)

The identification of the V600E activating mutation in the protein kinase BRAF in around 50% of melanoma patients has driven the development of highly potent small inhibitors (BRAFi) of the mutated protein. To date, Dabrafenib and Vemurafenib, two specifi

Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents

Wang, Shengzheng,Fang, Kun,Dong, Guoqiang,Chen, Shuqiang,Liu, Na,Miao, Zhenyuan,Yao, Jianzhong,Li, Jian,Zhang, Wannian,Sheng, Chunquan

, p. 6678 - 6696 (2015/09/07)

A critical question in natural product-based drug discovery is how to translate the product into drug-like molecules with optimal pharmacological properties. The generation of natural product-inspired scaffold diversity is an effective but challenging strategy to investigate the broader chemical space and identify promising drug leads. Extending our efforts to the natural product evodiamine, a diverse library containing 11 evodiamine-inspired novel scaffolds and their derivatives were designed and synthesized. Most of them showed good to excellent antitumor activity against various human cancer cell lines. In particular, 3-chloro-10-hydroxyl thio-evodiamine (66c) showed excellent in vitro and in vivo antitumor efficacy with good tolerability and low toxicity. Antitumor mechanism and target profiling studies indicate that compound 66c is the first-in-class triple topoisomerase I/topoisomerase II/tubulin inhibitor. Overall, this study provided an effective strategy for natural product-based drug discovery. (Figure Presented).

Novel TypeII Fatty Acid Biosynthesis (FAS II) Inhibitors as Multistage Antimalarial Agents

Schrader, Florian C.,Glinca, Serghei,Sattler, Julia M.,Dahse, Hans-Martin,Afanador, Gustavo A.,Prigge, Sean T.,Lanzer, Michael,Mueller, Ann-Kristin,Klebe, Gerhard,Schlitzer, Martin

, p. 442 - 461 (2013/08/25)

Malaria is a potentially fatal disease caused by Plasmodium parasites and poses a major medical risk in large parts of the world. The development of new, affordable antimalarial drugs is of vital importance as there are increasing reports of resistance to the currently available therapeutics. In addition, most of the current drugs used for chemoprophylaxis merely act on parasites already replicating in the blood. At this point, a patient might already be suffering from the symptoms associated with the disease and could additionally be infectious to an Anopheles mosquito. These insects act as a vector, subsequently spreading the disease to other humans. In order to cure not only malaria but prevent transmission as well, a drug must target both the blood- and pre-erythrocytic liver stages of the parasite. P.falciparum (Pf) enoyl acyl carrier protein (ACP) reductase (ENR) is a key enzyme of plasmodial typeII fatty acid biosynthesis (FASII). It has been shown to be essential for liver-stage development of Plasmodium berghei and is therefore qualified as a target for true causal chemoprophylaxis. Using virtual screening based on two crystal structures of PfENR, we identified a structurally novel class of FAS inhibitors. Subsequent chemical optimization yielded two compounds that are effective against multiple stages of the malaria parasite. These two most promising derivatives were found to inhibit blood-stage parasite growth with IC50 values of 1.7 and 3.0μM and lead to a more prominent developmental attenuation of liver-stage parasites than the gold-standard drug, primaquine.

Switching azonaphthols containing a side chain with limited flexibility. Part 1. Synthesis and tautomeric properties

Kurteva, Vanya B.,Antonov, Liudmil M.,Nedeltcheva, Daniela V.,Crochet, Aurélien,Fromm, Katharina M.,Nikolova, Rositsa P.,Shivachev, Boris L.,Nikiforova, Maya S.

experimental part, p. 1266 - 1277 (2012/04/04)

A series of azo dyes, possessing amide fragments with restricted flexibility tethered to 4-(phenyldiazenyl)naphthalen-1-ol, was obtained from 1-hydroxy-2-naphthoic acid by subsequent conversion to amides and diazo coupling. It was shown that the position of the tautomeric equilibrium in solution strongly depends on the solvent in both UV and NMR concentration scale. The compounds exist as pure enol forms in chloroform and hydrocarbons, while in polar solvents (acetone, acetonitrile, alcohols) a tautomeric mixture is observed. According to the quantum-chemical calculations the aggregation of the keto tautomer is the possible reason for this shift in the position of the tautomeric equilibrium. To support the theoretical predictions, it was found that from acetone the keto form crystallizes as a dimer with hydrogen bonding between N1-H in the one molecule and amide CO in the other forming a three-dimensional structure. The importance of the side-chain nitrogen atom on the dimer formation was confirmed by solution and solid state study of 4-(phenyldiazenyl)-2-acetylnaphthalen-1-ol. The results indicate that the new azo-dyes obtained could be suitable candidates for switching and sensing applications in non-polar solvents.

Design and synthesis of highly potent and selective (2-arylcarbamoyl- phenoxy)-acetic acid inhibitors of aldose reductase for treatment of chronic diabetic complications

Van Zandt, Michael C.,Sibley, Evelyn O.,McCann, Erin E.,Combs, Kerry J.,Flam, Brenda,Sawicki, Diane R.,Sabetta, Al,Carrington, Anne,Sredy, Janet,Howard, Eduardo,Mitschler, Andre,Podjarny, Alberto D.

, p. 5661 - 5675 (2007/10/03)

Recent efforts to identify treatments for chronic diabetic complications have resulted in the discovery of a novel series of highly potent and selective (2-arylcarbamoyl-phenoxy)-acetic acid aldose reductase inhibitors. The compound class features a core template that utilizes an intramolecular hydrogen bond to position the key structural elements of the pharmacophore in a conformation, which promotes a high binding affinity. The lead candidate, example 40, 5-fluoro-2-(4-bromo-2-fluoro-benzylthiocarbamoyl)-phenoxyacetic acid, inhibits aldose reductase with an IC50 of 30 nM, while being 1100 times less active against aldehyde reductase, a related enzyme involved in the detoxification of reactive aldehydes. In addition, example 40 lowers nerve sorbitol levels with an ED50 of 31 mg/kg/d po in the 4-day STZ-induced diabetic rat model.

Intramolecular oxygen versus carbon alkylation of naphthoate esters. A caveat on the mechanistic aspects of neocarzinostatin chemistry

Lamothe, Marie,Fuchs

, p. 4483 - 4496 (2007/10/02)

α-Hydroxy naphthoate esters are shown to be capable of undergoing intramolecular alkylation at carbon as well as at both oxygen centers. Basic reaction conditions favor intramolecular oxygen alkylation of the phenol moiety in addition to intramolecular carbon alkylation leading to spirolactones. Chemistry in neutral or acidic media appears to proceed via γ-oxo ketene acetal intermediates that are converted to products derived from addition of water followed by cleavage of the resultant orthoacid. γ-Oxo ketene acetal intermediates derived from naphthoate esters are at least 40 times more reactive than those derived from simple β-keto esters. These studies give credence to the proposal that the α-hydroxy naphthoate moiety in neocarzinostatin is capable of participation during the epoxide-opening reaction. Mechanistic consequences of such participation are discussed.

Naphthalide indicator dyes

-

, (2008/06/13)

This invention relates to indole (na) phthalide indicator dyes substituted with a particular class of hydrogen bonding groups, such as, perhaloalkyl carbinols. These dyes are useful as optical filter agents in photographic processes to protect a selectivity exposed photosensitive material from further exposure during processing in the presence of incident light.

Naphthalide indicator dyes

-

, (2008/06/13)

This invention relates to 1-naphthol (na)phthalide indicator dyes substituted with a particular class of hydrogen bonding groups, such as, perhaloalkyl carbinols. These dyes are useful as optical filter agents in photographic processes to protect a selectively exposed photosensitive material from further exposure during processing in the presence of incident light.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 38077-69-9